An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers

Trial Profile

An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Nov 2012

At a glance

  • Drugs Bardoxolone methyl (Primary) ; Digoxin; Rosuvastatin
  • Indications Arrhythmias; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemias; Hypertriglyceridaemia
  • Focus Pharmacokinetics
  • Sponsors Reata Pharmaceuticals
  • Most Recent Events

    • 29 Jun 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 29 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 19 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top